0.5245
전일 마감가:
$0.5418
열려 있는:
$0.54
하루 거래량:
1.13M
Relative Volume:
1.62
시가총액:
$19.59M
수익:
$53.55M
순이익/손실:
$-15.13M
주가수익비율:
-0.4856
EPS:
-1.08
순현금흐름:
$-23.86M
1주 성능:
-4.62%
1개월 성능:
+4.50%
6개월 성능:
+16.35%
1년 성능:
-37.19%
Cosmos Health Inc Stock (COSM) Company Profile
명칭
Cosmos Health Inc
전화
312-536-3102
주소
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
COSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
COSM
Cosmos Health Inc
|
0.5245 | 20.23M | 53.55M | -15.13M | -23.86M | -1.08 |
|
MCK
Mckesson Corporation
|
840.46 | 104.19B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
354.85 | 68.94B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
212.45 | 50.72B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
79.98 | 9.19B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.5902 | 840.28M | 2.22M | -5.63M | -1.68M | -0.24 |
Cosmos Health Inc 주식(COSM)의 최신 뉴스
Cosmos Health CEO Siokas acquires $220,000 in shares By Investing.com - Investing.com Australia
Cosmos Health CEO Siokas acquires $220,000 in shares - Investing.com
Zacks Small-Cap Research Initiates Coverage on Cosmos Health Inc. with $4.50 Valuation Per Share - Quiver Quantitative
AI research, crypto and $4.50 call put small-cap Cosmos Health on radar - Stock Titan
Cosmos Health CEO Siokas buys $57,000 in shares By Investing.com - Investing.com Nigeria
Cosmos Health CEO Siokas buys $57,000 in shares - Investing.com
Sunday’s Insider Activity: Big Buys at Zenas, Hycroft, and Major NVDA Sell - Investing.com Nigeria
Is Cosmos Health Inc. stock a defensive play in 2025July 2025 Trends & Accurate Intraday Trading Signals - Улправда
Cosmos Health Announces Launch Of Food Supplement Brand In Albania: Retail Sentiment Improves - MSN
Is Cosmos Health Inc. stock a safe haven assetStability vs Neutral Overview & support options for steady strides - Улправда
Cosmos Health Inc.Common Stock (NQ: COSM - FinancialContent
Insider Stock Purchases: January 09, 2026 - Quiver Quantitative
Cosmos Health CEO Siokas buys $81,000 in shares By Investing.com - Investing.com Canada
Cosmos Health CEO Siokas buys $81,000 in shares - Investing.com
Why Cosmos Health Inc. stock could see breakout soonPortfolio Profit Report & Consistent Profit Alerts - Улправда
Why Cosmos Health Inc. (V67A) stock could be next leaderDividend Hike & Verified Technical Signals - Улправда
How Cosmos Health Inc. stock reacts to Fed rate cutsEarnings Overview Report & Daily Price Action Insights - Улправда
How currency fluctuations impact Cosmos Health Inc. stockJuly 2025 Snapshot & Fast Moving Trade Plans - ulpravda.ru
Layoff Watch: What catalysts could drive Cosmos Health Inc stock higherWeekly Volume Report & Free Technical Pattern Based Buy Signals - Bộ Nội Vụ
Why Cosmos Health Inc. (V67A) stock trades below fair valueMarket Weekly Review & Technical Buy Zone Confirmation - ulpravda.ru
Why Cosmos Health Inc. stock could benefit from AI revolutionJobs Report & Expert Approved Momentum Ideas - Улправда
Cosmos Health CEO Siokas buys $65,000 in COSM stock By Investing.com - Investing.com South Africa
Cosmos Health CEO Siokas buys $65,000 in COSM stock - Investing.com
How Cosmos Health Inc. stock benefits from strong dollarJuly 2025 Closing Moves & Short-Term High Return Ideas - ulpravda.ru
Analysis Recap: How Cosmos Health Inc. stock reacts to Fed rate cuts2025 Institutional Moves & AI Driven Stock Movement Reports - Улправда
Insider Stock Purchases: January 07, 2026 - Quiver Quantitative
Cosmos Health CEO Siokas buys $72k in shares By Investing.com - Investing.com UK
Cosmos Health CEO Siokas buys $72k in shares - Investing.com
Cosmos Health to manufacture PathMuscle drug for Greek distributor By Investing.com - Investing.com Nigeria
Cosmos Health’s Wild Ride: Can COSM Survive Its Own Volatility? - AD HOC NEWS
Tangible book value per share of Cosmos Health Inc – MUN:V67A - TradingView — Track All Markets
Cosmos Health (COSM) Subsidiary to Manufacture PathMuscle for Li - GuruFocus
Cosmos Health stock rises on manufacturing deal with Libytec By Investing.com - Investing.com Nigeria
Cosmos Health stock rises on manufacturing deal with Libytec - Investing.com
Cosmos Health Inc. Subsidiary Cana Laboratories Enters Manufacturing Agreement for PathMuscle with Libytec Pharmaceutical in Greece - Quiver Quantitative
Cosmos Health to manufacture PathMuscle drug for Greek distributor - Investing.com
Cosmos Health Enters Manufacturing Agreement with Libytec - GlobeNewswire
About Us - FinancialContent
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units - Sahm
Cosmos Health Inc (COSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cosmos Health Inc 주식 (COSM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
| Siokas Grigorios | Chief Executive Officer |
Jan 08 '26 |
Buy |
0.52 |
156,190 |
81,000 |
7,131,794 |
| Siokas Grigorios | Chief Executive Officer |
Jan 07 '26 |
Buy |
0.52 |
124,880 |
65,000 |
6,975,604 |
| Siokas Grigorios | Chief Executive Officer |
Jan 06 '26 |
Buy |
0.54 |
133,953 |
72,000 |
6,850,724 |
| Siokas Grigorios | Chief Executive Officer |
Dec 19 '25 |
Buy |
0.49 |
88,314 |
43,000 |
6,716,771 |
| Siokas Grigorios | Chief Executive Officer |
Dec 15 '25 |
Buy |
0.42 |
168,472 |
70,000 |
6,628,457 |
| Siokas Grigorios | Chief Executive Officer |
Nov 28 '25 |
Buy |
0.64 |
76,360 |
49,000 |
6,459,985 |
| Siokas Grigorios | Chief Executive Officer |
Nov 25 '25 |
Buy |
0.63 |
55,732 |
35,000 |
6,383,625 |
| Siokas Grigorios | Chief Executive Officer |
Nov 21 '25 |
Buy |
0.68 |
56,080 |
38,000 |
6,327,893 |
| Siokas Grigorios | Chief Executive Officer |
Nov 20 '25 |
Buy |
0.62 |
51,315 |
32,000 |
6,271,813 |
자본화:
|
볼륨(24시간):